<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04471883</url>
  </required_header>
  <id_info>
    <org_study_id>00543186</org_study_id>
    <nct_id>NCT04471883</nct_id>
  </id_info>
  <brief_title>LATAM Bif Registry</brief_title>
  <official_title>Latin American Registry of Percutaneous Interventions in Coronary Bifurcations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LATAM Bifurcation Club</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LATAM Bifurcation Club</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The LATAM Bif Registy is an international and prospective registry of percutaneous coronary&#xD;
      interventions (PCI) in coronary bifurcation lesions. The main goal of the study is to&#xD;
      investigate the current state and long-term outcomes of PCI in this complex subset of&#xD;
      coronary lesions in Latin America.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 15, 2020</start_date>
  <completion_date type="Anticipated">August 15, 2030</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac Death</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial Infarction</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Target Lesion Revascularization</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Major bleeding</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Coronary Bifurcation Lesion</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous coronary interventions</intervention_name>
    <description>Percutaneous coronary interventions in coronary bifurcation lesions</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients â‰¥18 years of age, who have at least one significant lesion in a coronary&#xD;
        bifurcation on diagnostic cinecoronary angiography and who are candidates to treatment with&#xD;
        PCI, regardless of the dedicated-technique used. Those patients who present lesions&#xD;
        involving vessels &lt;2 mm by visual estimation and those who refuse to be included in the&#xD;
        registry will be excluded.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;= 18 years&#xD;
&#xD;
          -  Any type of bifurcation lesion&#xD;
&#xD;
          -  Side-branch reference diameter &gt;= 2 mm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Protected left main disease in patients with previous CABG&#xD;
&#xD;
          -  Patients who refuse to be included in the registry&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Marcelo A. Abud, M.D</last_name>
    <phone>54 11 33085742</phone>
    <email>latambif@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lucio T. Padilla, M.D</last_name>
    <email>latambif@gmail.com</email>
  </overall_contact_backup>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 10, 2020</study_first_submitted>
  <study_first_submitted_qc>July 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2020</study_first_posted>
  <last_update_submitted>July 10, 2020</last_update_submitted>
  <last_update_submitted_qc>July 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No IPD planned</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

